Federal Register / Vol. 82, No. 185 / Tuesday, September 26, 2017 / Notices 44815 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

Single-Award Deviations From 

Competition Requirements: Pediatric 

Emergency Care Applied Research 

Network 

AGENCY: Health Resources and Services 

Administration (HRSA), Department of 

Health and Human Services. 

ACTION: Notice of Single-Award 

Deviation from Competition 

Requirements for the Pediatric 

Emergency Care Applied Research 

Network (PECARN) at the Children’s 

Hospital Medical Center, Cincinnati, 

Ohio- Grant Number U03MC222684. 

SUMMARY: HRSA announces the award 

of a supplement of $50,000 for the 

PECARN cooperative agreement. The 

supplement will permit the Children’s 

Hospital Medical Center, Cincinnati, 

Ohio, the cooperative agreement 

recipient to support its oversight of the 

operation of PECARN as the Chair for 

2017–2018. 

SUPPLEMENTARY INFORMATION: 

Intended Recipient of the Award: 

Children’s Hospital Medical Center, 

Cincinnati, Ohio. 

Amount of Non-Competitive Awards: 

$50,000. 

Period of Supplemental Funding: 

September 1, 2017, through August 31, 

2018. 

CFDA Number: 93.127. 

Authority: Public Health Service Act, Title 

XIX, Section 1910 (42 U.S.C. 300w–9); as 

amended by the Emergency Medical Services 

for Children Reauthorization Act of 2014, 

P.L. 113–180. 

Justification: As stated in the funding 

opportunity announcement, the goal of 

the PECARN is to develop an efficient 

research network to conduct high 

quality research and publish evidencebased findings that will impact clinical 

practice and ensure standardized care in 

diverse health care settings that serve 

children, including urban, rural, and 

tribal settings. The objectives of this 

award are to: 

(1) Support a network infrastructure 

to conduct high priority, high impact 

EMSC research using rigorous study 

designs and methodologies that can be 

applied to multi-site Emergency 

Department and/or prehospital 

emergency settings; 

(2) Contribute to an organizational 

structure that ensures network 

efficiency, productivity, and fidelity of 

study implementation and includes the 

ability to: (a) Develop study projects; (b) 

Attain extramural funding; (c) Conduct 

multi-site clinical investigations; (d) 

Publish and disseminate results; and (e) 

Develop young investigators in the area 

of pediatric emergency medicine; 

(3) Facilitate translation of research 

results to EMSC practices; and 

(4) Foster collaboration among EMS 

personnel, nurses, practitioners, and 

researchers. 

Success of the PECARN requires the 

services of a Chair, who is elected on an 

annual basis by grantees. This annual 

supplement is necessary to support the 

Chair’s responsibilities which are 

within the scope of the cooperative 

agreement program, but were not 

required to be budgeted for in the 

organization’s application due to the 

unknown contingency of who would be 

elected as Chair on behalf of which 

organization. Dr. Richard Ruddy of 

Children’s Hospital Medical Center, 

Cincinnati, Ohio, was elected Chair of 

the PECARN for 2016–2018. The 

proposed supplement is to supply funds 

to the Chair to support his oversight of 

the operation of PECARN including 

coordinating and running the Steering 

Committee meetings, appointing 

Subcommittee Chairpersons to be later 

approved by the Steering Committee; 

maintaining ongoing communications 

with principal investigators and keeping 

all of PECARN updated with new/ 

ongoing activities; representing 

PECARN at national meetings; and 

serving as liaison to HRSA/Maternal 

and Child Health Bureau federal 

officials. 

FOR FURTHER INFORMATION CONTACT: 

Diane Pilkey, Division of Child, 

Adolescent and Family Health, Maternal 

and Child Health Bureau, Health 

Resources and Services Administration, 

5600 Fishers Lane, Room 18N58C, 

Rockville, MD 20852, Phone: 301–443– 

8927, Email: DPilkey@hrsa.gov. 

Grantee/organization name Grant No. State 

FY 2017 

Authorized 

funding level 

FY 2017 

Estimated 

supplemental 

funding 

Children’s Hospital Medical Center ................................................................... U03MC222684 OH $735,918 $50,000 

Dated: September 19, 2017. 

George Sigounas, 

Administrator. 

[FR Doc. 2017–20543 Filed 9–25–17; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

Non-competitive Fiscal Year 2017 

Supplemental Funding Award Ryan 

White HIV/AIDS Program, Part F 

Special Projects of National 

Significance 

AGENCY: Health Resources and Services 

Administration (HRSA), HHS. 

ACTION: Notice. 

SUMMARY: This non-competitive 

supplemental award to the University of 

California, San Francisco (UCSF), the 

Evaluation and Technical Assistance 

Center (ETAC) for the Culturally 

Appropriate Interventions of Outreach, 

Access and Retention among Latino/a 

Populations initiative, will support the 

costs of analysis, publication, and 

dissemination of findings and best 

practices learned from the initiative. 

SUPPLEMENTARY INFORMATION: 

Intended Recipient of the Award: 

UCSF (U90HA26507). 

Amount of Non-Competitive Award: 

$100,000. 

Period of Funding: September 1, 2017, 

through August 31, 2018. 

CFDA Number: No. 93.928. 

Authority: Public Health Service Act, 

Section 2691 (42 U.S.C. 300ff-101), as 

amended by the Ryan White HIV/AIDS 

Treatment Extension Act of 2009 (Pub. L. 

111–87). 

Justification: UCSF is currently 

conducting a multisite evaluation and 

providing technical assistance to the ten 

demonstration sites awarded under this 

initiative. The sites implement 

innovative interventions that identify 

Latinos/as at high risk or living with 

HIV in the United States, and improve 

their access, timely entry, and retention 

in quality HIV primary care. This 

supplemental funding will cover the 

costs of a special supplemental issue of 

a top-tier HIV/AIDS journal containing 

findings from the initiative, and support 

additional staff to assist in the analysis, 

publication, and dissemination of 

44816 Federal Register / Vol. 82, No. 185 / Tuesday, September 26, 2017 / Notices 

findings, best practices, and lessons 

learned. The supported activity includes 

the production of the required 

interventions manual for the initiative 

documenting the ten intervention 

models employed by the demonstration 

sites in order to promote the future 

replication of the interventions by Ryan 

White HIV/AIDS Program recipients and 

other health care providers. Not issuing 

this award would severely reduce the 

impact of this initiative by limiting the 

analysis and dissemination of best 

practices and lessons learned to HIV 

providers serving these Latino/a 

subpopulations. This would weaken 

efforts to improve the health outcomes 

for Latinos/as living with HIV in the 

United States. 

FOR FURTHER INFORMATION CONTACT: Mr. 

Adan Cajina, Chief, Demonstration 

Evaluation Branch, Office of Training 

and Capacity Development, Division of 

HIV Domestic Programs, HIV/AIDS 

Bureau, HRSA, 5600 Fishers Lane, 

09N108, Rockville, MD 20857, Phone: 

(301) 443–3180, Email: acajina@

hrsa.gov. 

Dated: September 19, 2017. 

George Sigounas, 

Administrator. 

[FR Doc. 2017–20541 Filed 9–25–17; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

National Vaccine Injury Compensation 

Program: List of Petitions Received 

AGENCY: Health Resources and Services 

Administration (HRSA), Department of 

Health and Human Services (HHS). 

ACTION: Notice. 

SUMMARY: HRSA is publishing this 

notice of petitions received under the 

National Vaccine Injury Compensation 

Program (the program), as required by 

the Public Health Service (PHS) Act, as 

amended. While the Secretary of HHS is 

named as the respondent in all 

proceedings brought by the filing of 

petitions for compensation under the 

Program, the United States Court of 

Federal Claims is charged by statute 

with responsibility for considering and 

acting upon the petitions. 

FOR FURTHER INFORMATION CONTACT: For 

information about requirements for 

filing petitions, and the Program in 

general, contact Lisa L. Reyes, Acting 

Clerk, United States Court of Federal 

Claims, 717 Madison Place NW., 

Washington, DC 20005, (202) 357–6400. 

For information on HRSA’s role in the 

Program, contact the Director, National 

Vaccine Injury Compensation Program, 

5600 Fishers Lane, Room 08N146B, 

Rockville, MD 20857; (301) 443–6593, 

or visit our Web site at: http://

www.hrsa.gov/vaccinecompensation/ 

index.html. 

SUPPLEMENTARY INFORMATION: The 

program provides a system of no-fault 

compensation for certain individuals 

who have been injured by specified 

childhood vaccines. Subtitle 2 of Title 

XXI of the PHS Act, 42 U.S.C. 300aa– 

10 et seq., provides that those seeking 

compensation are to file a petition with 

the U.S. Court of Federal Claims and to 

serve a copy of the petition on the 

Secretary of HHS, who is named as the 

respondent in each proceeding. The 

Secretary has delegated this 

responsibility under the Program to 

HRSA. The Court is directed by statute 

to appoint special masters who take 

evidence, conduct hearings as 

appropriate, and make initial decisions 

as to eligibility for, and amount of, 

compensation. 

A petition may be filed with respect 

to injuries, disabilities, illnesses, 

conditions, and deaths resulting from 

vaccines described in the Vaccine Injury 

Table (the Table) set forth at 42 CFR 

100.3. This Table lists for each covered 

childhood vaccine the conditions that 

may lead to compensation and, for each 

condition, the time period for 

occurrence of the first symptom or 

manifestation of onset or of significant 

aggravation after vaccine 

administration. Compensation may also 

be awarded for conditions not listed in 

the Table and for conditions that are 

manifested outside the time periods 

specified in the Table, but only if the 

petitioner shows that the condition was 

caused by one of the listed vaccines. 

Section 2112(b)(2) of the PHS Act, 42 

U.S.C. 300aa–12(b)(2), requires that 

‘‘[w]ithin 30 days after the Secretary 

receives service of any petition filed 

under section 2111 the Secretary shall 

publish notice of such petition in the 

Federal Register.’’ Set forth below is a 

list of petitions received by HRSA on 

August 1, 2017, through August 31, 

2017. This list provides the name of 

petitioner, city and state of vaccination 

(if unknown then city and state of 

person or attorney filing claim), and 

case number. In cases where the Court 

has redacted the name of a petitioner 

and/or the case number, the list reflects 

such redaction. 

Section 2112(b)(2) also provides that 

the special master ‘‘shall afford all 

interested persons an opportunity to 

submit relevant, written information’’ 

relating to the following: 

1. The existence of evidence ‘‘that 

there is not a preponderance of the 

evidence that the illness, disability, 

injury, condition, or death described in 

the petition is due to factors unrelated 

to the administration of the vaccine 

described in the petition,’’ and 

2. Any allegation in a petition that the 

petitioner either: 

a. ‘‘[S]ustained, or had significantly 

aggravated, any illness, disability, 

injury, or condition not set forth in the 

Vaccine Injury Table but which was 

caused by’’ one of the vaccines referred 

to in the Table, or 

b. ‘‘[S]ustained, or had significantly 

aggravated, any illness, disability, 

injury, or condition set forth in the 

Vaccine Injury Table the first symptom 

or manifestation of the onset or 

significant aggravation of which did not 

occur within the time period set forth in 

the Table but which was caused by a 

vaccine’’ referred to in the Table. 

In accordance with Section 

2112(b)(2), all interested persons may 

submit written information relevant to 

the issues described above in the case of 

the petitions listed below. Any person 

choosing to do so should file an original 

and three (3) copies of the information 

with the Clerk of the U.S. Court of 

Federal Claims at the address listed 

above (under the heading FOR FURTHER

INFORMATION CONTACT), with a copy to 

HRSA addressed to Director, Division of 

Injury Compensation Programs, 

Healthcare Systems Bureau, 5600 

Fishers Lane, 08N146B, Rockville, MD 

20857. The Court’s caption (Petitioner’s 

Name v. Secretary of HHS) and the 

docket number assigned to the petition 

should be used as the caption for the 

written submission. Chapter 35 of title 

44, United States Code, related to 

paperwork reduction, does not apply to 

information required for purposes of 

carrying out the program. 

Dated: September 19, 2017 

George Sigounas, 

Administrator. 

List of Petitions Filed 

1. Teresa Audino and David Audino on 

behalf of C. A., Vienna, Virginia 

Court of Federal Claims No: 17–1033V 

2. Stephanie C. Savage, Greensboro, 

North Carolina 

Court of Federal Claims No: 17–1036V 

3. Alfred Wade, Jr. on behalf of Elaine 

D. Wade, Deceased, Wilmington, 

North Carolina 

Court of Federal Claims No: 17–1039V 

4. Tiffany S. Gaiter and Deverett S. 

Gaiter on behalf of Deverett S. Jr. 

Gaiter, Bay City, Michigan